May 2017 FDA Recall Drug by Allergan Sales, Llc
D-0929-2017 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Allergan Sales, Llc on May 1, 2017 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0929-2017

Reason for Recall
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
Initiated
05-01-2017
Reported
07-05-2017
Quantity
648 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the US
Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.

Batch or Lot Expiration Information

Lot# Lot: 93802, EXP NOV 2019